News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,492 Results
Type
Article (86567)
Company Profile (702)
Press Release (761223)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232715)
Career Advice (4128)
Deals (39727)
Drug Delivery (129)
Drug Development (91001)
Employer Resources (198)
FDA (18125)
Job Trends (17342)
News (396535)
Policy (39761)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56861)
ALS (107)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (166)
Approvals (18074)
Artificial intelligence (347)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (324)
Cancer (2555)
Cardiovascular disease (215)
Career advice (3535)
Career pathing (34)
CAR-T (186)
Cell therapy (520)
Cervical cancer (22)
Clinical research (73604)
Collaboration (956)
Company closure (2)
Compensation (599)
Complete response letters (30)
COVID-19 (2875)
CRISPR (56)
C-suite (287)
Cystic fibrosis (111)
Data (2496)
Decentralized trials (2)
Denatured (46)
Depression (58)
Diabetes (310)
Diagnostics (6942)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (157)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (110)
Earnings (97359)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130492)
Executive appointments (815)
FDA (19613)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (860)
Gene editing (132)
Generative AI (36)
Gene therapy (389)
GLP-1 (873)
Government (5181)
Grass and pollen (6)
Guidances (174)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Indications (31)
Infectious disease (3040)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (106)
Interviews (813)
IPO (17851)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10120)
Liver cancer (82)
Lung cancer (360)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (384)
MASH (88)
Medical device (14653)
Medtech (14658)
Mergers & acquisitions (22475)
Metabolic disorders (836)
Multiple sclerosis (93)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2165)
NextGen: Class of 2025 (7682)
Non-profit (5084)
Now hiring (42)
Obesity (445)
Opinion (277)
Ovarian cancer (85)
Pain (106)
Pancreatic cancer (91)
Parkinson's disease (171)
Partnered (25)
Patents (268)
Patient recruitment (125)
Peanut (51)
People (65403)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22719)
Phase II (31972)
Phase III (24066)
Pipeline (1530)
Policy (187)
Postmarket research (3552)
Preclinical (10266)
Press Release (72)
Prostate cancer (116)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (451)
Real estate (7393)
Recruiting (75)
Regulatory (26865)
Reports (61)
Research institute (2660)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (50)
Schizophrenia (84)
Series A (150)
Series B (99)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (59)
The Weekly (84)
Vaccines (830)
Venture capitalists (45)
Weight loss (309)
Women's health (42)
Worklife (20)
Date
Today (182)
Last 7 days (912)
Last 30 days (3822)
Last 365 days (35560)
2025 (14031)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50221)
Australia (8844)
California (6967)
Canada (2165)
China (596)
Colorado (299)
Connecticut (316)
Delaware (174)
Europe (115273)
Florida (1016)
Georgia (235)
Hawaii (1)
Idaho (65)
Illinois (659)
India (31)
Indiana (350)
Iowa (13)
Japan (189)
Kansas (114)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1013)
Massachusetts (5314)
Michigan (260)
Minnesota (442)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (74)
New Hampshire (70)
New Jersey (1936)
New Mexico (31)
New York (1953)
North Carolina (1177)
North Dakota (10)
Northern California (3001)
Ohio (233)
Oklahoma (15)
Oregon (48)
Pennsylvania (1512)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (28)
South Dakota (1)
Southern California (2572)
Tennessee (111)
Texas (1043)
United States (26448)
Utah (205)
Virginia (186)
Washington D.C. (74)
Washington State (632)
West Virginia (3)
Wisconsin (76)
There are 848,492 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
May 20, 2025
·
4 min read
Press Releases
Enlivex Selected to Present at Israeli BioMed 2025 Conference
May 20, 2025
·
3 min read
Cardiovascular disease
Ionis Builds Triglyceride-Lowering Case for RNA-Targeting Tryngolza
The late-stage results come in advance of pivotal data that Ionis expects to provide for its antisense oligonucleotide Tryngolza in the third quarter, building up toward a regulatory submission in hypertriglyceridemia by year-end.
May 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection
May 20, 2025
·
5 min read
Press Releases
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms
May 20, 2025
·
5 min read
Press Releases
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
May 20, 2025
·
23 min read
Press Releases
Health Catalyst to Participate in Upcoming Investor Conferences
May 20, 2025
·
1 min read
Press Releases
TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR
May 20, 2025
·
3 min read
Press Releases
New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection
May 20, 2025
·
3 min read
Press Releases
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
May 20, 2025
·
3 min read
1 of 84,850
Next
